Zhou YL

Department of Psychiatry, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.

6 papers · ORCID

ArticleKetamine

Correction: Rapid treatment center for depression in China: constructive reflections and transnational implications.

Shi ZM, Huang XB, Zhou YL +4

Europe PMC2025
ArticleKetamine

Rapid treatment center for depression in China: constructive reflections and transnational implications.

Shi ZM, Huang XB, Zhou YL +4

Europe PMC2025
ArticlePsilocybin

Additions to the <i>Inocybe</i> sect. <i>Leptocybe</i> (Agaricales) in China: new species from tropical rainforests, new geographical distributions, and toxin detection.

Gao JL, Wu XP, Zhou YL +2

Europe PMC2025
ArticleKetamine

Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression.

Tan JQ, Gu LM, Zhou YL +4

Europe PMC2025
ArticleKetamine

Mapping metabolite change in the mouse brain after esketamine injection by ambient mass spectrometry imaging and metabolomics.

Liu GX, Li ZL, Lin SY +5

Europe PMC2023
ArticleKetamine

Sustained-Release Esketamine Based Nanoparticle-Hydrogel Delivery System for Neuropathic Pain Management.

Zhang H, Zhou P, Jiang Y +5

Europe PMC2023